APA (7th ed.) Citation

Sun, Q., Yang, X., Wang, Y., Yang, K., & Weng, Y. (2025). NAT10 Knockdown Improves Cisplatin Sensitivity in Non‐Small Cell Lung Cancer by Inhibiting the TRIM44/PI3K/AKT Pathway. Thoracic cancer, 16(9), e70079-n/a. https://doi.org/10.1111/1759-7714.70079

Chicago Style (17th ed.) Citation

Sun, Qi, Xiansong Yang, Ye Wang, Kejia Yang, and Yuan Weng. "NAT10 Knockdown Improves Cisplatin Sensitivity in Non‐Small Cell Lung Cancer by Inhibiting the TRIM44/PI3K/AKT Pathway." Thoracic Cancer 16, no. 9 (2025): e70079-n/a. https://doi.org/10.1111/1759-7714.70079.

MLA (9th ed.) Citation

Sun, Qi, et al. "NAT10 Knockdown Improves Cisplatin Sensitivity in Non‐Small Cell Lung Cancer by Inhibiting the TRIM44/PI3K/AKT Pathway." Thoracic Cancer, vol. 16, no. 9, 2025, pp. e70079-n/a, https://doi.org/10.1111/1759-7714.70079.